Literature DB >> 31981061

Sickness Behavior Score Is Associated with Neuroinflammation and Late Behavioral Changes in Polymicrobial Sepsis Animal Model.

Mariana Pereira de Souza Goldim1, Amanda Della Giustina1, Khiany Mathias1, Aloir de Oliveira Junior1, Maria Eduarda Fileti1, Raquel De Carli1, Graciela Zarbato1, Leandro Garbossa1, Naiana da Rosa1, Juliana Oliveira1, Andriele Vieira2, Jaqueline Generoso2, Bruna Hoffmann Oliveira3, Nivaldo Ferreira3, Juliete Palandi3, Franciane Bobinski3, Daniel Fernandes Martins3, Jucelia Fortunato1, Tatiana Barichello2,4,5, Joao Quevedo4,5,6,7, Felipe Dal-Pizzol2, Fabricia Petronilho8.   

Abstract

The use of reliable scores is a constant development in critical illness. According to Sepsis-3 consensus, the use of Sequential Organ Failure Assessment (SOFA) score of 2 or more is associated with a higher mortality of sepsis patients. In experimental research, due murine animal model limitations, the use of a score systems can be an alternative to assess sepsis severity. In this work, we suggest a sickness behavior score (SBS) that uses physiological variables to assess sepsis severity and mortality. Animals were evaluated daily by the presence of six indicators of sickness behavior: temperature alteration, preference of water/sucrose, liquid intake, food intake, body weight, and movimentation. Male adult Wistar rats were evaluated daily after sepsis induction by cecal ligation and puncture (CLP) or laparotomy only (sham) for determination of SBS. Oxidative stress, IL-6, and HPA axis markers (corticosterone and adrenal gland weight) were evaluated 24 h after CLP to determine the correlation with the acute SBS and neuroinflammation. Also, BDNF and four cognitive behavioral tests were correlated with the chronic SBS, i.e., sum of 8 days after surgery. In result, septic rats presented higher SBS than sham animals. Sepsis severity markers were associated with acute and chronic SBS. Also, SBS was negative correlated with the cognitive tests. In conclusion, SBS shows to be reliable score to predict sepsis severity and mortality. The use of score system provides the analysis of global sickness behavior, beyond evaluation of each parameter individually.

Entities:  

Keywords:  depression; memory; neuroinflammation; oxidative stress; sepsis; sickness behavior

Mesh:

Substances:

Year:  2020        PMID: 31981061     DOI: 10.1007/s10753-020-01187-z

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  5 in total

1.  Ketamine inhibits TNF-α-induced cecal damage by enhancing RIP1 ubiquitination to attenuate lethal SIRS.

Authors:  Bin Deng; Daowei Yang; Huanghui Wu; Lu Wang; Rui Wu; Hongrui Zhu; Ailing Huang; Jingyi Song; Tieliang Cai; Shanshan Liu; Jingsi Wu; Huiying Zhou; Chunhui Li
Journal:  Cell Death Discov       Date:  2022-02-19

Review 2.  Sepsis-associated brain injury: underlying mechanisms and potential therapeutic strategies for acute and long-term cognitive impairments.

Authors:  Nobufumi Sekino; Magdy Selim; Amjad Shehadah
Journal:  J Neuroinflammation       Date:  2022-04-29       Impact factor: 9.587

3.  Towards Modeling Anhedonia and Its Treatment in Zebrafish.

Authors:  Murilo S de Abreu; Fabiano Costa; Ana C V V Giacomini; Konstantin A Demin; Konstantin N Zabegalov; Gleb O Maslov; Yuriy M Kositsyn; Elena V Petersen; Tatiana Strekalova; Denis B Rosemberg; Allan V Kalueff
Journal:  Int J Neuropsychopharmacol       Date:  2022-04-19       Impact factor: 5.678

4.  Silencing of amygdala circuits during sepsis prevents the development of anxiety-related behaviours.

Authors:  Lena Bourhy; Aurélien Mazeraud; Luis H A Costa; Jarod Levy; Damien Rei; Estéban Hecquet; Ilana Gabanyi; Fernando A Bozza; Fabrice Chrétien; Pierre-Marie Lledo; Tarek Sharshar; Gabriel Lepousez
Journal:  Brain       Date:  2022-05-24       Impact factor: 15.255

5.  Neuronal MD2 induces long-term mental impairments in septic mice by facilitating necroptosis and apoptosis.

Authors:  Zhongmin Fan; Hongwei Ma; Yi Li; You Wu; Jiajia Wang; Lize Xiong; Zongping Fang; Xijing Zhang
Journal:  Front Pharmacol       Date:  2022-08-09       Impact factor: 5.988

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.